Multiparametric MRI and 18 F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer

Bastiaan M Privé,Bas Israël,Marcel J R Janssen,Marloes M G van der Leest,Maarten de Rooij,Jolique A van Ipenburg,Marianne Jonker,Steffie M B Peters,Michel de Groot,Patrik Zámecnik,Alexander Hoepping,Joyce G Bomers,Martin Gotthardt,J P Michiel Sedelaar,Jelle O Barentsz,Inge M van Oort,James Nagarajah
DOI: https://doi.org/10.1148/radiol.231879
IF: 19.7
2024-05-22
Radiology
Abstract:Background Multiparametric MRI (mpMRI) is effective for detecting prostate cancer (PCa); however, there is a high rate of equivocal Prostate Imaging Reporting and Data System (PI-RADS) 3 lesions and false-positive findings. Purpose To investigate whether fluorine 18 (^(18)F) prostate-specific membrane antigen (PSMA) 1007 PET/CT after mpMRI can help detect localized clinically significant PCa (csPCa), particularly for equivocal PI-RADS 3 lesions. Materials and Methods This prospective study...
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?